Figure 5 — Prediction of prognosis and immunotherapy efficacy based on metabolic landscape in lung adenocarcinoma by bulk, single-cell RNA sequencing and Mendelian randomization analyses

Research Paper|Volume 16, Issue 10|pp. 8772–8809

Prediction of prognosis and immunotherapy efficacy based on metabolic landscape in lung adenocarcinoma by bulk, single-cell RNA sequencing and Mendelian randomization analyses

Back to articleFigure 5(5 of 14)

100%

Figure 5.Evaluation of MPPS model in pan-cancer. (A) The Kaplan-Meier analysis of the high- and low-risk groups across 32 tumors in TCGA database except LUAD. The survival analysis was tested by log-rank test. (B–D) The 1-, 3-, 5-year AUC of MPPS model across 32 tumors in TCGA database except LUAD.